BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Thursday, April 25, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
July 19, 2010
View Archived Issues
Studies refine CAD-106 treatment regimen
Read More
Phase I trial shows safety MABT-5102-A in patients with AD
Read More
New HPV DNA vaccine AcHERV-HP16/18L1 is immunogenic in vivo
Read More
Poly-ICR can block suppression of anti-HPV immune responses
Read More
Glenmark Pharmaceuticals claims new TRPV3 channel inhibitors
Read More
Array BioPharma discovers new DP2 receptor inhibitors
Read More
Schering discloses novel nicotinic acid receptor agonists
Read More
Chinese scientists identify novel protein kinase inhibitors
Read More
AD candidate RQ-9 improves memory and cognition in rodents
Read More
Canagliflozin improves glucose control in persons with type 2 diabetes
Read More
Renovo provides update on product pipeline
Read More
Vernalis and Biogen to replace vipadenant in Parkinson's disease program
Read More
Supernus begins phase IIa SPN-812 trial in adults with ADHD
Read More
Lantheus launches Definity ultrasound contrast imaging product in India
Read More
Biolipox presents novel PDE4/PDE7 inhibitors
Read More
Elusys and Lonza extend contract to produce Anthim for inhalation anthrax
Read More
Galapagos and Bristol University to develop agents for diabetes-associated chronic pain
Read More
Nitric Bio begins phase II trial of terbinafine/device combination in onychomycosis
Read More
GTC regains rights to recombinant antithrombin ATryn
Read More
Amgen's denosumab BLA receives FDA priority review status
Read More
Biomet acquires substantially all assets of Cytosol Laboratories
Read More
Cangene's option to license Maxygen's MAXY-G34 for ARS expires
Read More
FDA extends PDUFA date for Walter Chilcott's Actonel product
Read More
Novo Nordisk completes recruitment in A1chieve trial of insulin regimens
Read More
Evotec gains new alliances in acquisition of DeveloGen
Read More